Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
The future of medicine is here
An essay by Vas Narasimhan, CEO of Novartis about the historical context and coming innovations in medicine with an introduction by Goran Mijuk.
Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
Hear from Director of Patient Services at AAMDSIF on how she supports patients with PNH, a blood disorder that significantly impacts quality of life.
Compassionate use: Providing access to much needed treatments
What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.
Prostate cancer and support of the care partner – Carl and Arlene’s story
When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
A scientist from the start – Q&A with NIBR President Fiona Marshall
In neuroscience, “an inflection point in knowledge and technology”
Let’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero
Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.
Renewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Sickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
A shared mission to take on the “impossible” in cancer research
Prostate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.